Weekly Investment Analysts’ Ratings Updates for Banco Bilbao Vizcaya Argentaria (BBVA)

Share on StockTwits

A number of firms have modified their ratings and price targets on shares of Banco Bilbao Vizcaya Argentaria (BME: BBVA) recently:

  • 2/8/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.40 ($7.44) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 2/4/2019 – Banco Bilbao Vizcaya Argentaria was given a new €5.40 ($6.28) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 2/1/2019 – Banco Bilbao Vizcaya Argentaria was given a new €5.60 ($6.51) price target on by analysts at Jefferies Financial Group Inc. They now have a “neutral” rating on the stock.
  • 2/1/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.80 ($7.91) price target on by analysts at JPMorgan Chase & Co.. They now have a “neutral” rating on the stock.
  • 2/1/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.60 ($7.67) price target on by analysts at Royal Bank of Canada. They now have a “buy” rating on the stock.
  • 2/1/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.90 ($8.02) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 1/22/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.12 ($7.12) price target on by analysts at Goldman Sachs Group Inc. They now have a “neutral” rating on the stock.
  • 1/21/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.90 ($8.02) price target on by analysts at UBS Group AG. They now have a “buy” rating on the stock.
  • 1/18/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.60 ($7.67) price target on by analysts at Royal Bank of Canada. They now have a “buy” rating on the stock.
  • 1/17/2019 – Banco Bilbao Vizcaya Argentaria was given a new €5.40 ($6.28) price target on by analysts at Credit Suisse Group AG. They now have a “neutral” rating on the stock.
  • 1/15/2019 – Banco Bilbao Vizcaya Argentaria was given a new €5.50 ($6.40) price target on by analysts at HSBC Holdings plc. They now have a “neutral” rating on the stock.
  • 1/11/2019 – Banco Bilbao Vizcaya Argentaria was given a new €5.40 ($6.28) price target on by analysts at Deutsche Bank AG. They now have a “neutral” rating on the stock.
  • 1/1/2019 – Banco Bilbao Vizcaya Argentaria was given a new €6.50 ($7.56) price target on by analysts at Royal Bank of Canada. They now have a “buy” rating on the stock.
  • 12/26/2018 – Banco Bilbao Vizcaya Argentaria was given a new €6.50 ($7.56) price target on by analysts at Royal Bank of Canada. They now have a “buy” rating on the stock.

Banco Bilbao Vizcaya Argentaria S.A. has a 1-year low of €6.51 ($7.57) and a 1-year high of €7.93 ($9.22).

Banco Bilbao Vizcaya Argentaria, SA, together with its subsidiaries, provides retail and wholesale banking, asset management, and private banking services. The company accepts various deposits, such as current and savings accounts, fixed-term deposits, subordinated deposits, and other accounts. It also offers loan products; and foreclosed real-estate assets from residential mortgages and developers, as well as lending to developers.

Recommended Story: Market Capitalization – What it Means for Investors

Receive News & Ratings for Banco Bilbao Vizcaya Argentaria SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Banco Bilbao Vizcaya Argentaria SA and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

TreeHouse Foods Inc.  Shares Sold by Bank of New York Mellon Corp
TreeHouse Foods Inc. Shares Sold by Bank of New York Mellon Corp
Bank of New York Mellon Corp Has $35.41 Million Position in iShares Exponential Technologies ETF
Bank of New York Mellon Corp Has $35.41 Million Position in iShares Exponential Technologies ETF
GlycoMimetics  Raised to Buy at BidaskClub
GlycoMimetics Raised to Buy at BidaskClub
BidaskClub Downgrades Duluth  to Sell
BidaskClub Downgrades Duluth to Sell
Camtek  Raised to “Buy” at BidaskClub
Camtek Raised to “Buy” at BidaskClub
Reata Pharmaceuticals Inc  Given Average Rating of “Buy” by Brokerages
Reata Pharmaceuticals Inc Given Average Rating of “Buy” by Brokerages


 
© 2006-2019 Zolmax.